Loading clinical trials...
Loading clinical trials...
This study proposes to use quetiapine as an adjunct treatment to treatment as usual to improve both substance use disorder (SUD) and mood symptoms in youth with SUD and severe mood dysregulation (SMD)...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boston Medical Center
Collaborators
NCT07140913 · Mania, Bipolar Disorder
NCT06413979 · Internalizing Disorders, Substance Use Disorders
NCT07172516 · Bipolar Disorder, Bipolar Depression, and more
NCT05492825 · Substance Use Disorders, Chronic Pain, and more
NCT04197921 · Opioid-use Disorder, Substance Use Disorders
Boston Medical Center
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions